Back to Search

MONT HIGHLEY, MD

MD

Family Medicine Physician

NPI: 1700850765Individual

Specialties, Licenses & Credentials

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

5501(AK)

Research & Publications (20)

A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract.
PMID 19269798·Clin Oncol (R Coll Radiol)·2009
3-trial
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.
PMID 19672264·Br J Cancer·2009
3-trial
CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.
PMID 19089662·J Gastrointest Cancer·2007
8-other
Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection.
PMID 16962394·J Chromatogr B Analyt Technol Biomed Life Sci·2007
8-other
Everolimus alters imatinib blood partition in favour of the erythrocyte.
PMID 16872552·J Pharm Pharmacol·2006
8-other
Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
PMID 16544888·J Sep Sci·2006
7-preclinical
In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.
PMID 16096439·Anticancer Drugs·2005
4-observational
In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender.
PMID 16096438·Anticancer Drugs·2005
4-observational
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study.
PMID 15860854·J Clin Oncol·2005
3-trial
Phase I study of TNFalpha AutoVaccIne in patients with metastatic cancer.
PMID 15754205·Cancer Immunol Immunother·2005
3-trial
Vascular endothelial growth factor and angiogenesis.
PMID 15602010·Pharmacol Rev·2004
6-review
The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment.
PMID 15576286·Clin Chem Lab Med·2004
6-review
Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.
PMID 14661754·J Chromatogr A·2003
8-other
Pharmacology of anticancer drugs in the elderly population.
PMID 14606930·Clin Pharmacokinet·2003
6-review
A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor.
PMID 12684399·Clin Cancer Res·2003
3-trial
Interaction between paclitaxel and warfarin.
PMID 12598362·Ann Oncol·2003
5-case
Hyphenated techniques in anticancer drug monitoring. II. Liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry.
PMID 12462615·J Chromatogr A·2002
6-review
Hyphenated techniques in anticancer drug monitoring. I. Capillary gas chromatography-mass spectrometry.
PMID 12462614·J Chromatogr A·2002
6-review
Oxidative DNA damage: biological significance and methods of analysis.
PMID 12385502·Crit Rev Clin Lab Sci·2002
6-review
The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors.
PMID 12172503·Anticancer Drugs·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
7104 UNIVERSITY COURT
MONTGOMERY, AL 36117

Location

Practice Location

7104 UNIVERSITY COURT, MONTGOMERY, AL
(334) 215-0711

Quick Facts

NPI
1700850765
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile